Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Glycinate for COVID-19 in Patients with MS and DM2
NCT04626089Phase 2Withdrawn
- Sponsor
- Laboratorios Silanes
- Start
- Feb 2021
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Metformin glycinate in coronavirus disease 2019 (COVID-19), sponsored by Laboratorios Silanes. Planned start Feb 2021; status: withdrawn.
02
Drugs
Metformin glycinate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04626089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04626089.